Martin Forrest | VP of IR & Corporate Communications |
Aron Knickerbocker | CEO |
Dr. Helen Collins | CMO |
David Smith | CFO |
Jonathan Chang | SVB Leerink |
Timor Vanicus | Raymond James |
Charles Xu | Guggenheim Securities |
Chris Shibutani | Cowen |
Tony Butler | Roth Capital Partners |
Maryana Breitman | Goldman Sachs |
Eric Joseph | JP Morgan |
Nick Abbott | Wells Fargo |
Welcome to the Five Prime Therapeutics Second Quarter 2019 Earnings Call.
As a reminder, this conference call is being recorded.
I'd like now to introduce your host for today's conference, Martin Forrest, Vice President, Investor Relations and Corporate Communications.
You may begin.
Thank you, Sarah.